These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

606 related items for PubMed ID: 23897229

  • 1. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK, Abdul-Rahman IS, Al-Muhanna FA, Al-Sulaiman MH, Al-Jondebi MS, Divino-Filho JC.
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [Abstract] [Full Text] [Related]

  • 2. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B.
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [Abstract] [Full Text] [Related]

  • 3. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A, Weisz M, Kathuria P.
    Adv Perit Dial; 2009 Feb; 25():56-9. PubMed ID: 19886318
    [Abstract] [Full Text] [Related]

  • 4. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
    Wong PN, Tong GM, Wong YY, Lo KY, Chan SF, Lo MW, Lo KC, Ho LY, Tse CW, Mak SK, Wong AK.
    Perit Dial Int; 2016 Feb; 36(3):340-6. PubMed ID: 27044796
    [Abstract] [Full Text] [Related]

  • 5. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.
    Chu KH, Choy WY, Cheung CC, Fung KS, Tang HL, Lee W, Cheuk A, Yim KF, Chan WH, Tong KL.
    Perit Dial Int; 2008 Feb; 28(5):505-8. PubMed ID: 18708544
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V.
    Adv Perit Dial; 2000 Feb; 16():257-61. PubMed ID: 11045306
    [Abstract] [Full Text] [Related]

  • 12. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW, HONEYPOT Study Collaborative Group.
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [Abstract] [Full Text] [Related]

  • 13. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L, Vardhan A, Mahajan S, Smart B, Hutchison A, Gokal R.
    J Nephrol; 2004 Dec; 17(2):242-5. PubMed ID: 15293524
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG.
    Perit Dial Int; 1998 Dec; 18(3):261-70. PubMed ID: 9663889
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R.
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.